T ooth loss is frequently accompanied by a progressive alveolar bone absorption, a situation that triggers bone ridge atrophy and causes difficulty to the placement of conventional or implant-supported prostheses, while osseointegrated implants can barely or not be installed at all. [1] [2] [3] [4] Therefore, preservation of the alveolar process in areas of tooth loss and adoption of procedures that minimize bone loss or recuperate the desirable alveolar ridge dimensions are important goals in dental practice.
Clinical situations as those described above benefit from the use of biomaterials that may substitute for lost bone or stimulate osteogenesis. The most predictable results for replacement, reconstruction, or filling of bone defects are still obtained with the use of autogenous porous bone grafts, nevertheless, their shortcomings such as surgical morbidity of the donor source and limited availability of healthy graft material. The alternatives to autografts include homogenous (allogenic) and heterogenous (xenogenic) bone grafts, besides a variety of synthetic materials, each of them presenting specific chemical compositions and physical characteristics that are more adequate for particular applications. 1, 5 The availability and low cost of bovine bone, allied to the adequate processing that minimizes the risks of infection transmission, have led Brazilian, Canadian, and European companies to produce bovine bone grafts for medical and dental applications. 1, 6 Heterogenous inorganic bone graft consists of matrix fragments in which the organic components are removed, and the mineralized elements, consisting mainly of hydroxyapatite, attain an osteoconductive surface behavior. 1, 4, 7 A variety of synthetic materials has been used to fill bone defects; among them the bioactive glasses, which are silica-based, surface-active compounds with the ability to bond directly to bone and also exert an osteoconductive property. 8 Although the studies on biomaterials have progressed considerably, the great variability of clinical and experimental models has made it difficult to evaluate the results in order to define the best material for specific dental or medical employments. The purpose of the present study was to compare, by histologic and histometric analysis, the behavior of inorganic bovine bone and bioactive glass particles grafted in the rat alveolar socket immediately after tooth extraction, as well as their interference with the alveolar bone healing. Carried out in the same animal specie and in an identical experi-mental model, the species-specific and among receptor bones differences, which might make comparisons unviable, were reduced.
MATERIALS AND METHODS
Male Wistar rats (250 g initial body weight) were anesthetized with 2,2,2-tribromoethanol (25 mg/100 g body weight intraperitoneally; Aldrich, Milwaukee, WI), and the upper right incisors were extracted. Immediately after tooth extraction, the alveolar socket of some of the animals was filled with particles of either inorganic lyophilized bovine bone matrix (Genox®, Genius®; Baumer, São Paulo, SP, Brazil; particles of 0.25-1.00 mm in diameter) or bioactive glass (PerioGlas®; USBiomaterials Corp., Jacksonville Beach, FL; particles of 90 -710 m in diameter) mixed with a minimum volume of sterile saline and introduced with the aid of flexible polyethylene cannula and embolus. The wounds in the control (nongrafted) and grafted animals were sutured with mononylon 4-0 (Ethicon, Johnson & Johnson, São José dos Campos, SP, Brazil), and a single dose (0.2 mL per rat, intramuscularly) of a polyvalent veterinary antibiotic (Pentabiótico Veterinário; Wyeth, São Bernardo do Campo, SP, Brazil) was administered. The rats were housed under a climate-controlled environment (12 hours light/12 hours dark; 22 Ϯ 3°C) with free access to standard laboratory chow and tap water. All procedures were conducted in compliance with ethical principles for animal research, as approved by institutional guidelines (Protocol 04.1.669.53.4).
The animals were killed with an intraperitoneal overdose of sodium pentobarbital 1, 2, 3, and 9 weeks postoperatively (n ϭ 5 per group in the 1 and 3-week groups, for histological analysis; n ϭ 10 per group in the 2 and 9-week groups, for histological and histometric analysis), and the heads were immersed in 10% formalin solution for 48 hours. After fixation, the maxillae were dissected free, decalcified, and processed for paraffin embedding. Semi-serial longitudinal 6-m-thick sections of the hemimaxillae containing the alveolar sockets were cut at 60-m intervals and stained with hematoxylin and eosin.
Histometric Analysis
The degree of new bone formation inside the alveolar socket was estimated at the end of the second and ninth postoperative weeks in the cervical alveolar third (where the grafted particles were located), by a differential point-counting method using an integration eyepiece with 100 equidistant points. A total of 500 points were counted in 5 histological sections per alveolus (final magnification ϫ100), the percentage of points lying on the particles, on the connective tissue or on bone trabeculae being proportional to their volume density. The measures were standardized in the grafted and nongrafted sockets to avoid interference of regional differences in the rate of bone healing. The healing process, which in this phase consists of a gradual replacement of connective tissue by bone trabeculae, was estimated by new bone volume fraction (percent bone trabeculae relative to bone trabeculae plus connective tissue). The nonparametric Mann-Whitney and Kruskal-Wallis tests (␣ ϭ 0.05 for statistical significance) were used to analyze differences among groups.
RESULTS
Both inorganic bone and bioactive glass particles of irregular shape and variable size were observed partially filling the cervical third of the alveolar sockets (Figs. 1A and 2A), and their presence evoked neither a foreign body reaction nor a persisting inflammatory response.
In the animals grafted with inorganic bone (Fig. 1) , by the end of the first week, an osteoid matrix forming from the inner surfaces of the alveolar walls approached the particles of the material but did not establish a direct contact with their surface. By the second week, neoformed bone trabeculae were in close contact with the surface of some particles, and in a few of them, narrow absorption lacunae filled by connective tissue were observed. By the third and ninth weeks, the amount and maturation of new bone trabeculae interposed among the particles progressed, and in some cases, a close contact between them was noticed. The amount of particles presenting larger absorption lacunae filled by Hematoxylin and eosin. Particles of irregular shape and variable size filling the cervical third of the alveolar socket (original magnification ϫ50) (A). Neoformed bone trabeculae (bt) interposed among the grafted particles and, in some cases, in close contact with their surface (arrowheads) (original magnification ϫ100) (B). Inorganic bovine bone particle exhibiting a narrow absorption lacunae filled by connective tissue (empty arrow) (original magnification ϫ100) (C). Inorganic bovine bone particle showing new bone trabeculae in close contact with its surface (filled arrows) and absorption lacunae filled by mineralized bone surrounding medullary vascularized connective tissue (empty arrow) (original magnification ϫ200) (D).
connective tissue increased, and by the ninth week, in a few particles, thicker absorption lacunae filled by mineralized bone trabeculae surrounding a medullary vascularized connective tissue were observed.
In the animals grafted with bioactive glass (Fig. 2) , by the end of the first week, an osteoid matrix interposing among the particles and occasionally in close contact with their surface was observed. By the second week, the particles were surrounded by mineralized new bone trabeculae, and in some particles, narrow absorption lacunae filled by connective tissue were observed, likewise in the inorganic bone grafted group. By the third and ninth weeks, as the reparation osteogenesis developed, the particles were progressively enclosed by an increasing amount of neoformed bone, which in several cases was in close contact with their surface. In some particles, the absorption lacunae were filled by connective tissue with discrete areas of osteoid matrix.
The histometric analysis showed that the volume fraction of inorganic bone particles filling the cervical third of the alveolar socket was similar to that of bioactive glass particles in both 2 and 9-week groups. The volume fraction of the cervical alveolar third occupied by the materials was 50% to 80% in the 2-week period and 50% to 62% in the 9-week period (Fig. 3) . The histometric data also confirmed a progressive new bone formation in the cervical alveolar third from the second to the ninth week in both grafted and control groups, although more discrete in the bioactive glass group, and showed that the presence of either inorganic bone or bioactive glass particles impaired the alveolar bone healing. In the 2-week period, the delay in bone healing was more pronounced in the animals grafted with inorganic bone than in those grafted with bioactive glass, and in the 9-week period an opposing situation was observed (Fig. 4) .
DISCUSSION
In the present study, the different phases of alveolar healing were recognized by histological examination of the sockets of control and grafted rats from 1 to 9 weeks after tooth extraction. The chronology of the healing process that follows tooth extraction has been well established in humans and different animal species. Shortly after tooth extraction, due to the rupture of blood vessels from the apical region and periodontal ligament, the socket is filled with blood, which immediately coagulates. Capillary sprouting and fibroblasts originating from periodontal ligament remnants Fig. 3 . Percent of inorganic bovine bone (IB) and bioactive glass (BG) particles (median and interquartile intervals, number of animals in parenthesis) in the alveolar cervical third, 2 and 9 weeks after grafting (Mann-Whitney statistical test). No statistically significant difference between groups was attained at each experimental period.
Fig. 2.
Rat alveolar socket at 1 (A and B), 2 (C and D), and 9 (E) weeks after tooth extraction and grafting with bioactive glass (BG) particles. Hematoxylin and eosin. Particles of irregular shape and variable size filling the cervical third of the alveolar socket (original magnification ϫ100) (A). Osteoid matrix in close contact with a particle surface (arrow) (original magnification ϫ200) (B). Mineralized new bone trabeculae interposed among the particles and a particle showing absorption lacunae filled by connective tissue (empty arrow) (original magnification ϫ50) (C). Neoformed bone trabeculae in close contact with a particle surface (filled arrow) (original magnification ϫ100) (D). Bioactive glass particle exhibiting neoformed bone trabeculae in close contact with its surface (filled arrow) and absorption lacunae filled by connective tissue with as discrete area of osteoid matrix (empty arrow) (original magnification ϫ200) (E).
and surrounding tissues invade the coagulum, and, as wound healing progresses, the blood clot is gradually absorbed and replaced by immature connective (granulation) tissue, which becomes progressively denser at the same time as the amount of inflammatory cells and blood vessels decreases and osteoblasts become evident. The osteoblasts initially synthesize an immature bone matrix (osteoid) that is further mineralized by calcium deposition as hydroxyapatite crystals. The alveolar bone neoformation takes place from the apical and lateral walls toward the center of the alveolus, and the healing process culminates with filling of the dental socket by trabecular bone. 9 -12 Although histologic analyses have suggested that the rat alveolar healing is completed by the end of the third week after tooth extraction, 13 quantitative studies have shown a discrete but significant increase in bone neoformation up to the sixth 10 or eighth 12 week. Nevertheless, it has been proved that the major proportion of bone formation 14 and maximum mineral bone density 12 take place by the end of the second week. In the present study, the histometric analysis of bone healing was carried out at the end of the second and ninth weeks after tooth extraction, thus comprising both the period of maximum new bone formation and end of the healing process.
Histometric data in the present study showed that similar volume fractions of the cervical alveolar sockets were occupied by inorganic bone or bioactive glass particles 2 and 9 weeks after implantation. Moreover, the volume fraction of both materials was only discretely smaller after the 9-week period than after the 2-week period. Despite an attempt to achieve a more profound implantation, due to the curvature of the extraction socket and also probably to the pressure exerted by bleeding, the materials were superficially located. Moreover, despite an effort to standardize the grafting procedures, it was not possible to determine the precise amount of particles introduced in the socket, and, thus, a comparison between periods was not possible. It is worth emphasizing, however, the small variability observed in the material volume density both between animals and between experimental groups.
Distinct biomaterials have proper absorption rates when grafted in biological environments, due not only to the particle size but also to their chemical nature. In the present study, absorption lacunae were observed only in a few particles of inorganic bone up to 9 weeks after implantation, confirming the extremely slow absorption rate of this grafting material. [15] [16] [17] [18] In a recent review of biomaterials for human maxillary sinus augmentation, inorganic bone was considered to be a nonabsorbable grafting material. 19 Likewise, absorption lacunae initially filled by connective tissue and subsequently presenting areas of osteoid matrix were observed only in some bioactive glass particles, suggesting this as a slowly degradable material. There are reports of an almost complete absorption of PerioGlas® particles 12 weeks after grafting in standardized bony defects produced in femoral condyles of rabbits 20 -21 and 24 weeks after grafting in mandibular defects in monkeys. 22 Particles of another type of bioactive glass (Biogran®; Orthovita, Malvern, PA; 300 -355 m in diameter) presented a significant absorption only 25 weeks after grafting in mandibular defects in monkeys. 23 Reports suggesting a rather fast degradation and/or resorption of bioactive glass particles have been questioned. 24 The biocompatibility, as well as the osteointegrative and osteoconductive properties attributed to inorganic bovine bone grafts 18, 25 were corroborated in the present study, which also confirmed that the material can delay bone healing. Experimental and clinical studies from the 1950s and 1960s recommended inorganic bone grafts for correction of oral and craniofacial bone defects. This material, however, has been reported to elicit an intense and persistent inflammatory reaction in the tooth extraction socket of rats, consequently delaying alveolar bone healing. 26, 27 Bio-Oss® (Geistlich Pharma AG, Wolhusen, Switzerland) is a grafting inorganic bone chemically and structurally comparable to that used in the present study, and has been tested in medical and dental clinics since the 1990s with reports of biocompatibility, osseointegration, and osteoconduction properties. 18, 25 Both clinical and histological analyses in humans have suggested that this is a material adequate for filling tooth extraction sockets, 28 and correcting alveolar bone ridges 29 and periodontal osseous defects.
30 Stavro- poulos et al, 24 however, have emphasized that most of the clinical reports are descriptive and vague, lacking appropriate controls, and have warned that conclusions based merely on clinical and radiographic studies might be imprecise. Besides, although histometric studies of maxillary sinus augmentation 15 and healing of extraction socket 16 in humans have suggested that the volume density of reparation bone is not negatively affected by BioOss®, it is worth mentioning that both studies also lack appropriate (nongrafted) controls.
Experimental studies carried out on animals have shown that particles of Bio-Oss® implanted subperiosteally for alveolar ridge augmentation and heterotopically in the rat abdominal muscle exhibited no osteoconductive property and induced a foreign body reaction in both cases. 31 A possible benefit of their use for correction of calvaria bone defects in rats and mandibular bone defects in dogs has also been contested. 24 A histometric study in rats also confirmed that grafting Bio-Oss® as an adjunct to guided tissue regeneration arrests new bone formation in mandibular bone defects.
In the present study, although exhibiting biocompatibility as well as osteoconductive and osteointegrative properties, the bioactive glass particles grafted in the alveolar socket impaired bone healing. It has been postulated that bioactive glass particles implanted into organic tissues are transformed by a specific ion exchange process responsible for their osteoconductive, osteointegrative, and osteostimulatory properties. Initially, a silica-rich gel layer is formed, upon which an in situ calcium phosphate layer is gradually precipitated. Subsequently, organic species are incorporated into this bioactively developing layer, and osteoblasts are attracted to form new bone attached to the particles' surface. At the same time, fissures and lacunae forming in the particles enable osteoprogenitor cells to enter within this protected space and differentiate into osteoblasts, which form new bone without any connection with bone tissue outside the particles; this unique response of bioactive glass to biological tissues and fluids has been called osteostimulatory property. [32] [33] [34] Clinical and radiographic investigations have suggested the efficacy of bioactive glass particles, particularly PerioGlas®, in the treatment of human bone defects resulting from periodontal disease, cyst resection, or apicectomy, as well as in the maintenance of alveolar bone ridge and recuperation of atrophic alveolar processes for placement of osseointegrated implants. 32, [35] [36] [37] [38] Some of the authors, however, have recognized the need for histological analysis to support these findings, but histological and histometric assessment has not always confirmed clinical expectations. In this respect, no significant difference was observed in the percent of healing bone in human extraction sockets filled with bioactive glass compared to control (unfilled) sockets. 39 Moreover, only a small amount of reparation bone was detected by histological analysis in human extraction sites 6 months after grafting with bioactive glass for the placement of osseointegrated implant. 40 Likewise, although the clinical and radiographic results were encouraging, histological analysis revealed that, as a periodontal grafting material, bioactive glass has only a limited regenerative capability. 41, 42 Despite the emphasized osteostimulatory property of bioactive glass in dental clinical practice, experimental results are still controversial. The effectiveness of bioactive glass particles in promoting a higher reparation osteogenesis as compared to unfilled bone defects or defects grafted with hydroxyapatite and tricalcium phosphate has been attested by histological analysis in monkey 22 and dog 33 mandibular bone, as well as in monkey periodontal defects 43 and dog tooth extraction sockets. 44 Histometric data attested also the positive action of PerioGlas® grafted in the extraction socket, reversing the adverse effect of osteoporosis on alveolar bone healing in female rats. 45 In this study, however, the presence of bioactive glass particles inside the socket of normal (nonosteoporotic) females tended to impair the bone healing process on a long-term basis (9 weeks). Likewise, the deleterious long-term effect of Biogran® arresting bone formation when used as an adjunct to guided tissue regeneration in rats mandibular defects was reported. 24 It has been suggested that the osteoconductive and osteostimulatory properties of bioactive glass result in part from the uniformity of the particles within a narrow size range. It has been assumed that in particles smaller than 200 m, resorption occurs too rapidly and may cause inflammation, and, conversely, particles larger than 400 m remain unreacted and are not resorbed, thus preventing new bone formation 34 ; an ideal 300 -355-m size range has been considered. 33 As a consequence, Biogran®, with particles of a narrower size range (300 -355 m) than PerioGlas® (90 -710 m), would be more favorable to the formation of absorption lacunae and to osteoblastic cell migration, resulting in a more prominent osteostimulatory property. Nevertheless, a histometric study 46 aiming to compare the effects of both materials grafted in bone defects of rabbits showed more new bone formation in the animals grafted with PerioGlas®, and, in contrast to the manufacturer's information, the mean particle diameter was larger for Biogran® (ranging from 457.9 to 1312.5 m) than for PerioGlas® (ranging from 94.4 to 964.8 m). The authors described absorption lacunae in both materials, more frequently in particles of PerioGlas® (32%) than in particles of Biogran® (16%) 12 weeks after grafting.
The histometric data in the present study revealed that inorganic bone graft had a more pronounced deleterious effect on alveolar bone healing than bioactive glass particles during the 2-week period, although an opposite result was observed during the 9-week period. It is possible that liberation of silica, calcium, and phosphorous, which takes place during the first days after the contact of bioactive glass particles with biological fluids and is responsible for their osteostimulatory property, 20 may have partially compensated for the negative effect of the physical presence of this material, precisely at the time when migration, proliferation, and differentiation of cells of the osteoblastic lineage take place.
To our knowledge, there is no report in the literature on the short-term effects of grafting bioactive glass compared to inorganic bone on clinical or experimental bone defects. However, comparison of bioactive glass and synthetic hydroxyapatite as grafting materials seems to favor the former both on a short-term and longterm basis. 33 There is histometric evidence of a faster and higher reparation osteogenesis after grafting bioactive glass in bone defects of rabbit femur as compared to grafting synthetic hydroxyapatite (both materials with particle size ranging from 100 to 300 m). 20 Similar results were reported after a long-term histological analysis of monkey mandibular defects grafted with Biogran® compared to defects grafted with synthetic hydroxyapatite.
23
The present result for the 9-week period group corroborates the report of Schmitt et al 47 comparing the effect of grafting critical-sized defects in the rabbit radius with inorganic bone (Bio-Oss®) or bioactive glass (PerioGlas®). Histological and histometric analysis carried out 4 and 8 weeks later showed that the amount of new bone was significantly greater in the defects grafted with inorganic bone after both experimental periods. BioOss® appeared also to be more effective than PerioGlas® when used as an adjunct to guided tissue regeneration in the rat mandibular bone defect model on a long-term basis. 24 The reason why inorganic bone graft, which presents only an osteoconductive property, can be less deleterious or more effective than bioactive glass in the long term, in case this result is confirmed in other experimental models, deserves further investigation.
CONCLUSIONS
Both inorganic bovine bone and bioactive glass particles grafted in the incisor extraction socket of rats, although biocompatible and capable of osseointegration, delayed new bone formation. Histometric data showed that the degree of impairment resulted from a combination of factors, such as the type of material and phase of the reparation process. Although a direct extrapolation to the clinical aspect is improper, the present results reaffirm the need for reflection about the use of biomaterials to substitute lost bone or stimulate osteogenesis.
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All authors claim to have no financial interest in any company or any of the products mentioned in this article. Comparar histométricamente, en ratas, la curación del hueso luego de injertar las cavidades de extracción incisivas con hueso bovino inorgánico o partículas bioactivas de vidrio. Material y Métodos: Se estimó la fracción de volumen de los materiales injertados y los componentes de la curación alveolar en imágenes histológicas al final de la segunda y novena semana posteriores a la operación a través de un método diferencial de cuenta de puntos. Resultados: Se observó histológicamente a ambos materiales mientras llenaban parcialmente el tercer alveolo cervical y, a pesar de que no crearon una reacción contra un cuerpo extraño ni una respuesta inflamatoria persistente, retrasaron la formación del nuevo hueso en lugares de prueba alrededor de sus partículas. Al llegar a la segunda semana, el retraso en la curación del hueso fue más pronunciada en los animales injertados con hueso inorgánico que con el vidrio bioactivo y se observó un resultado inverso en un período de 9 semanas. Conclusión: Ambos, el hueso bovino inorgánico y las partículas bioactivas de vidrio injertados en la cavidad incisiva de extracción de ratas retrasaron la formación del nuevo hueso y el grado de deterioro resultó de una combinación de factores tales como el tipo de material y la fase del proceso de reparación. Comparar histometricamente, em ratos, a cura do osso após enxertar os alvéolos de extração de incisivos com osso bovino inorgânico ou partículas de vidro bioativo. Material e Métodos: A fração de volume de materiais enxertados e componentes de cura alveolar foi estimada em imagens histológicas no fim da 2 a e 9 a semana pós-operação por um método de diferencial do contagem de pontos. Resultados: Ambos os materiais foram observados histologicamente, preenchendo parcialmente o terço cervical e, embora não evocando nem uma reação a corpo estranho nem uma resposta inflamatória persistente, atrasou a nova formação de osso em áreas de teste em torno de suas partícu-las. Por volta da 2 a semana, o atraso na cura do osso foi mais pronunciada nos animais enxertados com inorgânico do que naqueles enxertados com vidro bioativo e um resultado posto foi observado num período de 9 semanas. Conclusão: Tanto o osso bovino inorgânico quanto as partículas de vidro bioativo enxertados nos alvéolos de extração dos incisivos de ratos atrasaram a nova formação de osso, e o grau de prejuízo resultou de uma combinação de fatores, tais como tipo de material e fase do processo de reparação. 
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